scholarly article | Q13442814 |
P50 | author | Daniel J Buysse | Q90217822 |
P2093 | author name string | Evelyn Mai | |
P2860 | cites work | Relationship between chronic painful physical condition and insomnia | Q48570349 |
Hyperarousal and insomnia | Q48584312 | ||
Job stress, social support, and prevalence of insomnia in a population of Japanese daytime workers | Q48586551 | ||
Increased utilization of health services by insomniacs--an epidemiological perspective | Q48591534 | ||
Daytime activity and risk factors for late-life insomnia | Q48620203 | ||
NREM sleep EEG frequency spectral correlates of sleep complaints in primary insomnia subtypes. | Q48651231 | ||
Prevalence of insomnia and associated factors in South Korea | Q48655885 | ||
The relationship between insomnia and health-related quality of life in patients with chronic illness | Q48663819 | ||
Sleep complaints predict coronary artery disease mortality in males: a 12-year follow-up study of a middle-aged Swedish population | Q48667919 | ||
Self-reported hyperarousal traits among insomnia patients | Q48685063 | ||
Epidemiology of severe insomnia and its consequences in Germany | Q48691385 | ||
Beta/Gamma EEG activity in patients with primary and secondary insomnia and good sleeper controls | Q48703544 | ||
Prevalence of insomnia in a survey of 12,778 adults in France | Q48726476 | ||
The direct costs of insomnia in France | Q48755571 | ||
The direct economic costs of insomnia in the United States for 1995. | Q48755598 | ||
Characteristics of insomnia in the United States: results of the 1991 National Sleep Foundation Survey. I. | Q48755820 | ||
Clinical correlates of insomnia in patients with chronic illness. | Q48799115 | ||
Daytime Alertness in Patients with Chronic Insomnia Compared with Asymptomatic Control Subjects | Q48960543 | ||
Insomnia and its treatment. Prevalence and correlates | Q49048494 | ||
Risk factors associated with complaints of insomnia in a general adult population. Influence of previous complaints of insomnia | Q68008455 | ||
The socioeconomic impact of insomnia. An overview | Q33573309 | ||
Sleep disturbance preceding completed suicide in adolescents | Q33660640 | ||
Insomnia and heart disease: a review of epidemiologic studies | Q33806559 | ||
Evaluation of chronic insomnia. An American Academy of Sleep Medicine review | Q33875617 | ||
Insomnia: definition, prevalence, etiology, and consequences | Q34006700 | ||
Place of chronic insomnia in the course of depressive and anxiety disorders | Q34164790 | ||
Risk factors for late-life insomnia in a representative general practice sample. | Q34214195 | ||
A psychiatric perspective on insomnia. | Q34270905 | ||
Practice Parameters for Using Polysomnography to Evaluate Insomnia: An Update | Q34271631 | ||
Insomnia: symptom or diagnosis? | Q34389671 | ||
Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? | Q34541877 | ||
The role of actigraphy in sleep medicine | Q35046830 | ||
Primary insomnia: a risk factor to develop depression? | Q35207859 | ||
Insomnia as a health risk factor | Q35984963 | ||
Insomnia: pathophysiology and implications for treatment | Q36686710 | ||
Prevalence of sleep disorders in the Los Angeles metropolitan area | Q39206929 | ||
Prevalence and risk factors of insomnia in community-dwelling Chinese elderly: a Taiwanese urban area survey | Q39692686 | ||
Comorbidity of chronic insomnia with medical problems | Q40238715 | ||
Prevalence and correlates of clinical insomnia co-occurring with chronic back pain. | Q40241135 | ||
Economic effects of insomnia. | Q40595288 | ||
Epidemiology of insomnia: what we know and what we still need to learn | Q40610246 | ||
24-Hour metabolic rate in insomniacs and matched normal sleepers | Q40973654 | ||
Insomnia and absenteeism at work. Who pays the cost? | Q43716680 | ||
Prevalence, burden, and treatment of insomnia in primary care | Q44196979 | ||
The morbidity of insomnia uncomplicated by psychiatric disorders | Q44319923 | ||
Does insomnia kill? | Q44768123 | ||
Professional correlates of insomnia | Q44939935 | ||
Functional neuroimaging evidence for hyperarousal in insomnia | Q45130119 | ||
Medical and socio-professional impact of insomnia. | Q45239747 | ||
The impact and prevalence of chronic insomnia and other sleep disturbances associated with chronic illness | Q46148004 | ||
Sleep problems and their correlates in a working population | Q46153581 | ||
Actigraphy in the assessment of insomnia | Q47342287 | ||
Improving actigraphic sleep estimates in insomnia and dementia: how many nights? | Q48459120 | ||
Practice parameters for the use of actigraphy in the assessment of sleep and sleep disorders: an update for 2007. | Q48468125 | ||
The direct and indirect costs of untreated insomnia in adults in the United States | Q48472282 | ||
Psychological factors and insomnia among male civil servants in Japan. | Q48474298 | ||
A comparison of actigraphy and polysomnography in older adults treated for chronic primary insomnia | Q48486709 | ||
The association of insomnia with anxiety disorders and depression: exploration of the direction of risk | Q48490390 | ||
Actigraphy validation with insomnia. | Q48511848 | ||
Epidemiology of DSM-IV insomnia in adolescence: lifetime prevalence, chronicity, and an emergent gender difference | Q48514973 | ||
Precipitating factors of insomnia | Q48569671 | ||
P433 | issue | 2 | |
P921 | main subject | insomnia | Q1869874 |
P304 | page(s) | 167-174 | |
P577 | publication date | 2008-01-01 | |
P1433 | published in | Sleep Medicine Clinics | Q15767234 |
P1476 | title | Insomnia: Prevalence, Impact, Pathogenesis, Differential Diagnosis, and Evaluation | |
P478 | volume | 3 |
Q88502091 | A Multimethod Examination of the Effect of Insomnia Symptoms on Anxious Responding to a Social Stressor |
Q37220464 | A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia |
Q47673202 | A randomized clinical trial examining the effects of an anxiety sensitivity intervention on insomnia symptoms: Replication and extension |
Q36761304 | A randomized controlled trial of problem-solving therapy compared to cognitive therapy for the treatment of insomnia in adults |
Q22305705 | AMBER LENSES TO BLOCK BLUE LIGHT AND IMPROVE SLEEP: A RANDOMIZED TRIAL |
Q35857923 | Adverse Respiratory Events Associated With Hypnotics Use in Patients of Chronic Obstructive Pulmonary Disease: A Population-Based Case-Control Study |
Q64949107 | Association between Sedative-hypnotics and Subsequent Cancer in Patients with and without Insomnia: A 14-year Follow-up Study in Taiwan. |
Q33880876 | Association between physical activity and insomnia symptoms in rural communities of southeastern Missouri, Tennessee, and Arkansas |
Q47715499 | Attenuation of short wavelengths alters sleep and the ipRGC pupil response |
Q51743326 | Auricular acupressure for insomnia in hemodialysis patients: study protocol for a randomized controlled trial. |
Q37253959 | Characteristics and Trends in Hypnotics Consumption in the Largest Health Care System in Israel |
Q37512649 | Clinical Trial Research on Mongolian Medical Warm Acupuncture in Treating Insomnia. |
Q34125876 | Cognitive behavioral therapy vs. Tai Chi for late life insomnia and inflammatory risk: a randomized controlled comparative efficacy trial |
Q96769224 | Combined impact of ADHD and insomnia symptoms on quality of life, productivity, and health care use in the general population |
Q54966077 | Development of an Algorithm to Identify Patients with Physician-Documented Insomnia. |
Q38133545 | Disrupted nighttime sleep in narcolepsy |
Q38423386 | Effects of estrogen therapy on postmenopausal sleep quality regardless of vasomotor symptoms: a randomized trial |
Q34466786 | Efficacy of Viola odorata in Treatment of Chronic Insomnia |
Q47114424 | Electric Field Exposure Improves Subjective Symptoms Related to Sleeplessness in College Students: A Pilot Study of Electric Field Therapy for Sleep Disorder. |
Q40397247 | Enhancing CBT for Chronic Insomnia: A Randomised Clinical Trial of Additive Components of Mindfulness or Cognitive Therapy. |
Q89466403 | Environmental Determinants of Insufficient Sleep and Sleep Disorders: Implications for Population Health |
Q40063975 | Immigration and Sleep Problems in a Southern European Country: Do Immigrants Get the Best Sleep? |
Q90285810 | Increased Risk of Benign Paroxysmal Positional Vertigo in Patients With Non-Apnea Sleep Disorders: A Nationwide, Population-Based Cohort Study |
Q39015232 | Insomnia Management in the Australian Primary Care Setting |
Q37719011 | Insomnia and the Risk of Atrial Fibrillation: A Population-Based Cohort Study. |
Q37733925 | Insomnia in Iranian traditional medicine |
Q50140185 | Insomnia in the Older Adult. |
Q24193264 | Interventions for insomnia during pregnancy |
Q35176909 | Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis. |
Q37952599 | Nocturia × disturbed sleep: a review |
Q89635060 | Non-alcoholic fatty liver disease among patients with sleep disorders: a Nationwide study of Taiwan |
Q38806112 | On-call work: To sleep or not to sleep? It depends |
Q36720900 | Pain in Community-Dwelling Elderly African Americans |
Q36070248 | Perceived inadequate care and excessive overprotection during childhood are associated with greater risk of sleep disturbance in adulthood: the Hisayama Study |
Q37633349 | Predictive Modeling of Physician-Patient Dynamics That Influence Sleep Medication Prescriptions and Clinical Decision-Making |
Q38718879 | Prevalence of insomnia and related impact |
Q42696536 | Prevalence, predictors and correlates of insomnia in US army soldiers |
Q36430588 | Quality of life in patients suffering from insomnia |
Q92882532 | Rice bran extract supplement improves sleep efficiency and sleep onset in adults with sleep disturbance: A randomized, double-blind, placebo-controlled, polysomnographic study |
Q35542038 | Risk of psychiatric disorders in patients with chronic insomnia and sedative-hypnotic prescription: a nationwide population-based follow-up study. |
Q57170037 | Sex Differences in Insomnia: from Epidemiology and Etiology to Intervention |
Q89165697 | Sleep Disorders in Multiple Sclerosis |
Q58541161 | Sleep and cardiovascular disease: Emerging opportunities for psychology |
Q47781730 | Sleep disturbance and depressive affect in patients treated with haemodialysis |
Q38690396 | Sleep loss as a trigger of mood episodes in bipolar disorder: individual differences based on diagnostic subtype and gender |
Q30362407 | The Dual Hypocretin Receptor Antagonist Almorexant is Permissive for Activation of Wake-Promoting Systems. |
Q52620508 | The Pilot Survey of the Perception on the Practice Pattern, Diagnosis, and Treatment on Korean Medicine Insomnia: Focusing on the Difference between Korean Medical Neuropsychiatry Specialists and Korean Medical General Practitioners. |
Q37251289 | The association of relational and organizational job stress factors with sleep disorder: analysis of the 3rd Korean working conditions survey (2011) |
Q37535058 | The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats |
Q40356348 | The relationship between insomnia with short sleep duration is associated with hypercholesterolemia: a cross-sectional study |
Q58797209 | Too Imperfect to Fall Asleep: Perfectionism, Pre-sleep Counterfactual Processing, and Insomnia |
Search more.